Hypothalamic Hormones and Cancer
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Frontiers in Neuroendocrinology
- Vol. 22 (4) , 248-291
- https://doi.org/10.1006/frne.2001.0217
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Isolation and properties of the FSH and LH-releasing hormonePublished by Elsevier ,2004
- A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude miceEuropean Journal Of Cancer, 2001
- Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-IICancer, 2000
- Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumoursEuropean Journal Of Cancer, 2000
- Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238International Journal of Cancer, 1999
- Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095European Journal Of Cancer, 1998
- Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-IIEuropean Journal Of Cancer, 1997
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982